Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4799-4806

  Ebrahimi Shahmabadi, Hasan ^a   Movahedi, Fatemeh ^a   Koohi Moftakhari Esfahani, Maedeh ^a   Alavi, Seyed Ebrahim ^a   Eslamifar, Ali ^a   Mohammadi Anaraki, Gholamreza ^b   Akbarzadeh, Azim ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain tumor; Cisplatin; Drug delivery; In vivo study; PBCA NPs

Indexed keywords

CISPLATIN; DRUG CARRIER; NANOCARRIER; NANOPARTICLE; OLIVE OIL; POLYBUTYL CYANOACRYLATE NANOPARTICLE; POLYSORBATE 80; STABILIZING AGENT; SURFACTANT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ENBUCRILATE;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFICACY; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; FREEZE DRYING; GLIOBLASTOMA; HONEY; IC 50; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIVER NECROSIS; MALE; NANOENCAPSULATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PRODUCTIVITY; RAT; SCANNING ELECTRON MICROSCOPE; SENTINEL LYMPH NODE; SPECTROMETER; SURVIVAL TIME; WEIGHT CHANGE; ZETA POTENTIAL; ANIMAL; BRAIN TUMOR; CHEMISTRY; SOLUBILITY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CISPLATIN; DRUG CARRIERS; DRUG STABILITY; ENBUCRILATE; GLIOBLASTOMA; MALE; NANOPARTICLES; RATS; RATS, WISTAR; SOLUBILITY;

EID: 84902972033     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1630-9     Document Type: Article

References (35)

1. Beduneau A, Saulnier P, Benoit J. Active targeting of brain tumors using nanocarriers. Biomaterials. 2007;28:4947-67. (Pubitemid 47362345)
2. Tian XH, Lin XN, Wei F, Feng W, Huang ZC, Wang P, et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine. 2011;6:445-52.
3. Chakraborty C, Sarkar B, Hsu C, Wen Z, Lin C, Shieh P. Future prospects of nanoparticles on brain targeted drug delivery. J Neurooncol. 2009;93:285-6.
4. Pardridge W. Blood - brain barrier delivery. Drug Discov Today. 2007;12:54-61.
5. Wolburg H, Lippoldt A. Tight junctions of the blood - brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38:323-37. (Pubitemid 36398254)
6. Masserini M. Nanoparticles for brain drug delivery. ISRN Biochem. 2013;2013:18.
7. Garcia-Garcia E, Andrieux K, Gilb S, Couvreur P. Colloidal carriers and blood - brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm. 2005;298:274-92. (Pubitemid 40910731)
8. Koffie R, Farrar C, Saidi L, William C, Hyman B, Spires-Jones T. Nanoparticles enhance brain delivery of blood - brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci U S A. 2011;108:18837-42.
9. Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem. 2009;284:6972-81.
10. Dikpati A, Madgulkar AR, Kshirsagar SJ, Bhalekar MR, Singh Chahal A. Targeted drug delivery to CNS using nanoparticles. JAPS. 2012;2:179-91.
11. De Jonghe B, Horn C. Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus). Am J Physiol Regul Integr Comp Physiol. 2009;296:902-11.
12. Wilson JJ, Lopes JF, Lippard SJ. Synthesis, characterization, and photophysical properties of three platinum(II) complexes bearing fluorescent analogues of the Di-2-pyridylmethane ligand. Inorg Chem. 2010;49:5303-15.
13. Savrikar S, Lagad C. Study of preparation and standardization of 'Maadhutailika Basti' with special reference to emulsion stability. Ayu. 2010;31:1-6.
14. Fontes G, Amaral P, Nele M, Coelho M. Factorial design to optimize biosurfactant production by Yarrowia lipolytica. J Biomed Biotechnol. 2010;2010:1-8.
15. Miura F, Alves M, Rocha M, Silva R, Oba-Shinjo S, Uno M, et al. Experimental model of C6 brain tumors in athymic rats Arq. Neuro-Psiquiatria. 2008;66:238-41. (Pubitemid 351883909)
16. Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer. 2004;109:759-67. (Pubitemid 38405625)
17. Sreelakshmi C, Datta KK, Yadav JS, Reddy BV. Honey derivatized Au and Ag nanoparticles and evaluation of its antimicrobial activity. J Nanosci Nanotechnol. 2011;11:6995-7000.
18. Wu L, Cai X, Nelson K, Xing W, Xia J, Zhang R, et al. A green synthesis of carbon nanoparticle from honey for real-time photoacoustic imaging. Nano Res. 2013;6:312-25.
19. Palanisamy KL, Meenakshi Sundaram N, Devabharathi V, Thangarasu P. Synthesis and characterization of olive oil mediated iron oxide nanoparticles. Dig J Nanomater Bios. 2013;2:607-12.
20. Yan X, Gemeinhart RA. Cisplatin delivery from poly (acrylic acid-co-methyl methacrylate) microparticles. J Control Release. 2005;106:198-208. (Pubitemid 41149078)
21. Ebrahimi Shahmabadi H, Akbarzadeh A, Mokhtari MJ, Mortazavi M, Ghasemi S, Mohammadi H, et al. In vitro evaluation of the effects of acetone, on the potency of cisplatin: is it a good candidate for cisplatin carrier preparation? E3 J Biotechnol Pharm Res. 2012;3:137-40.
22. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2012;64:246-55.
23. Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly (butyl cyanoacrylate) nanoparticles. Int J Pharm. 2010;400:211-20.
24. Macka M, Borák J, Seménková L, Kiss F. Decomposition of cisplatin in aqueous solutions containing chlorides by ultrasonic energy and light. J Pharm Sci. 1994;83:815-8. (Pubitemid 24233756)
25. Kante B, Couvreur P, Dubois-Krack G, De Meester C, Guiot P, Roland M, et al. Toxicity of polyalkylcyanoacrylate nanoparticles I: free nanoparticles. J Pharm Sci. 1982;71:786-90.
26. De Angelis LM. Brain tumours. N Engl J Med. 2001;344:114-23.
27. Nelson DF, Nelson JS, Davis DR, Chang CH, Griffin TW, Pajak TF. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol. 1985;3:99-103. (Pubitemid 15001542)
28. Kornblith PL, Walker M. Chemotherapy for malignant gliomas. J Neurosurg. 1998;68:1-17.
29. Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep. 2013;3:2534.
30. Parsa AT, Chakrabarti I, Hurley PT, Chi JH, Hall JS, Kaiser MG, et al. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy. Neurosurgery. 2000;47:993-9.
31. Barth R, Kaur B. Rat brain tumor models in experimental neurooncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 2009;94:299-312.
32. Petri B, Bootz A, Khalansky A, Hekmatara T, Muller R, Uhl R. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated Poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release. 2007;117:51-8. (Pubitemid 46164866)
33. Olivier JC, Fenart L, Chauvet R, Pariat C, Cecchelli R, Couet W. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm Res. 1999;16:1836-42. (Pubitemid 30040699)
34. de Verdière AC, Dubernet C, Némati F, Soma E, Appel M, Ferté J, et al. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br J Cancer. 1997;76:198-205.
35. Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, et al. Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol. 2010;28:1145-53.